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Research
Polychlorinated biphenyls (PCBs), industrial
chemicals that were produced and sold in the
United States for approximately 50 years
(Kimbrough 1985), have continued to bio-
accumulate throughout the ecosystem. PCBs
are highly lipophilic, with octanol:water parti-
tion coefﬁcients of ≥ 104 and, as such, accumu-
late markedly in lipid-rich tissues (Kodavanti
et al. 1998). In lean people, white adipose tis-
sue makes up approximately 15–25% of body
weight, and this amount is increased by > 50%
in cases of morbid obesity (Mullerova and
Kopecky 2006). Thus, the capacity of adipose
tissue to accumulate lipophilic PCBs is consid-
erable and would be anticipated to increase
with obesity.
The prevalence of obesity has increased at
an alarming rate, with 65.4% of the adult
population in the United States overweight
and 30.5% of adults exhibiting obesity
(Flegal et al. 2002; Hedley et al. 2004). Even
more alarming, the prevalence of overweight
children in the age range of 6–11 years
increased from 4.2% in 1963 to 15.3% in
1999–2000 (Ogden et al. 2002). Reaven
(1988) noted that several risk factors for
cardiovascular disease cluster around an obesity
phenotype, termed the metabolic syndrome.
Cardiovascular disease has been identiﬁed as a
primary clinical outcome of patients diag-
nosed with the metabolic syndrome (Grundy
et al. 2004, 2006). Of the cardiovascular dis-
eases associated with obesity, atherosclerosis is
a primary cause of death in obese patients
(Grundy et al. 2004). Thus, it is important to
define mechanisms contributing to the
development of obesity and that link obesity
to cardiovascular disease.
Interesting recent ﬁndings suggest that in
nondiabetics with the metabolic syndrome,
PCBs were linearly associated with waist cir-
cumference (Lee et al. 2007b). Because serum
concentrations of PCBs show decreasing
trends but obesity is at epidemic proportions,
the authors suggested that the toxicity of
PCBs may synergistically increase as people
become obese (Lee et al. 2007b). Despite the
potential for adipocytes to be frequently
exposed to PCBs, the speciﬁc effects of PCBs
on adipocyte function have not been deﬁned.
Moreover, the impact of enhanced PCB
sequestration in the expanded adipose mass
with obesity on the development of obesity-
associated cardiovascular diseases is unknown.
Previous results demonstrated that copla-
nar 3,3´,4,4´-tetrachlorobiphenyl (PCB-77),
an aryl hydrocarbon receptor (AhR) ligand,
promoted inflammation in endothelial cells
(Hennig et al. 1999, 2002a, 2005; Lim et al.
2007). Adipocytes express the AhR (Shimba
et al. 1998); however, it is unclear whether
coplanar PCBs will also induce expression of
inflammatory cytokines in adipocytes.
Induction of proinflammatory cytokines by
PCBs in adipocytes would be anticipated to
promote the development of obesity and
obesity-associated cardiovascular disease
(Mullerova and Kopecky 2006). In the pre-
sent study, we contrasted the concentration-
dependent effects of coplanar PCB-77 versus
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
on adipocyte differentiation using 3T3-L1
adipocytes. Because PCB-77 has been demon-
strated to induce inflammatory pathways in
endothelial cells (Hennig et al. 1999, 2002b,
2005; Lim et al. 2007), we examined the
effects of PCB-77 on proinflammatory and
anti-inflammatory adipokine expression in
3T3-L1 adipocytes. To extend these in vitro
findings, we defined the in vivo effects of
PCB-77 on body weight gain in C57BL/6
and AhR–/– mice. In separate studies, to deter-
mine whether effects of PCB-77 would pro-
mote cardiovascular diseases linked to obesity,
we defined the effects of PCB-77 on the
development of obesity, alterations in serum
lipids, and atherosclerosis in apolipoprotein E
(apoE)–/– mice.
Materials and Methods
PCB-77, 2,2´,4,4,5,5´-hexachlorobiphenyl
(PCB-153), and TCDD were obtained from
AccuStandard Inc. (New Haven, CT).
α-Naphthoflavone (α-NF) was obtained
from Sigma Aldrich (St. Louis, MO).
Cell culture and treatment. 3T3-L1 mouse
embryo ﬁbroblasts, purchased from American
Type Culture Collection (Manassas, VA) were
maintained in standard Dulbecco’s modiﬁed
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BACKGROUND: Obesity, an inﬂammatory condition linked to cardiovascular disease, is associated
with expansion of adipose tissue. Highly prevalent coplanar polychlorinated biphenyls (PCBs)
such as 3,3´,4,4´-tetrachlorobiphenyl (PCB-77) accumulate in adipose tissue because of their
lipophilicity and increase with obesity. However, the effects of PCBs on adipocytes, obesity, and
obesity-associated cardiovascular disease are unknown.
OBJECTIVES: In this study we examined in vitro and in vivo effects of PCB-77 on adipocyte differ-
entiation, proinflammatory adipokines, adipocyte morphology, body weight, serum lipids, and
atherosclerosis.
METHODS: PCB-77 or 2,2´,4,4,5,5´-hexachlorobiphenyl (PCB-153) was incubated with 3T3-L1
adipocytes either during differentiation or in mature adipocytes. Concentration-dependent effects of
PCB-77 were contrasted with those of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). For in vivo
studies, we treated C57BL/6 wild-type (WT) or aryl hydrocarbon receptor (AhR)–/– mice with vehi-
cle or PCB-77 (49 mg/kg, by intraperitoneal injection) and examined body weight gain. In separate
studies, we injected ApoE–/– mice with vehicle or PCB-77 over a 6-week period and examined body
weight, adipocyte size, serum lipids, and atherosclerosis.
RESULTS: Low concentrations of PCB-77 or TCDD increased adipocyte differentiation, glycerol-3-
phosphate dehydrogenase activity, and expression of peroxisome proliferator–activated receptor γ,
whereas higher concentrations inhibited adipocyte differentiation. Effects of PCB-77 were abolished
by the AhR antagonist α-naphthoﬂavone. PCB-77 promoted the expression and release of various
proinflammatory cytokines from 3T3-L1 adipocytes. Administration of PCB-77 increased body
weight gain in WT but not AhR–/– mice. ApoE–/– mice injected with PCB-77 exhibited greater body
weight, adipocyte hypertrophy, serum dyslipidemia, and augmented atherosclerosis.
CONCLUSIONS: Our ﬁndings suggest that PCB-77 may contribute to the development of obesity
and obesity-associated atherosclerosis.
KEY WORDS: adipocyte differentiation, aryl hydrocarbon receptor, ectopic lipid deposition, obesity,
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Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS; Gemini Bio-Products,
Woodland, CA) and 1% penicillin/strepto-
mycin and subcultured in 60-mm cell culture
dishes. Cultured cells (passage number 6 or
lower) were allowed to grow to 100% con-
fluence at 37°C in a humidified 5% CO2
atmosphere with media changes every
2–3 days. For each experimental parameter
measured, assays were performed on dupli-
cate wells of cells within an individual
experiment, with a total of three to five
experimental replicates. 
To deﬁne the effects of PCBs on adipocyte
differentiation, we incubated preadipocytes
with PCB-77 or PCB-153 (3.4 µM) (Hennig
et al. 1999, 2002b) 1 day before the induction
of differentiation through day 8 of differentia-
tion. Differentiation was induced by incubat-
ing cells for 2 days with a cocktail containing
insulin (0.1 µM; Sigma, St. Louis, MO), dexa-
methasone (1 µM; Sigma), and isobutylmethyl
xanthine (0.5 mM, IBMX; Sigma). On the
third day, the media was changed to contain
only insulin for 1 day, followed by DMEM
with 10% FBS for a total of 8 days. Cells were
harvested for measurement of oil red O stain-
ing, glycerol-3-phosphate dehydrogenase
(GPDH) activity, or mRNA quantiﬁcation of
gene expression. 
In separate experiments, to contrast con-
centration-dependent effects of PCB-77 to
TCDD, we incubated preadipocytes with
vehicle [0.03% dimethyl sulfoxide (DMSO)],
PCB-77 (3.4 or 68 µM), or TCDD (0.1, 1, or
10 nM) beginning on day –1 through day 8 of
differentiation. Cells were harvested on day 8
for measurement of oil red O staining. To
define the role of the AhR in PCB-77–
induced regulation of adipocyte differentia-
tion, preadipocytes were incubated with
20 µM α-NF for 30 min before the addition
of vehicle, PCB-77 (3.4 µM), or TCDD
(0.1 nM) on day 1 through day 8 of differenti-
ation. Cells were harvested on day 8 for meas-
urement of oil red O staining.
To deﬁne the effects of PCBs on mature
adipocytes, preadipocytes were differentiated
using the protocol described above and vehi-
cle, PCB-77 (3.4 µM), or PCB-153 (3.4 µM)
was added to the media on day 8 for 24 or
48 hr. Cells were then harvested for mRNA
quantification of gene expression and oil
red O staining. Cell media was assayed for
cytokines as described below.
Oil red O staining. Cells were washed
once with sterile phosphate-buffered saline
(PBS) and fixed with 10% formaldehyde in
PBS for 5 min at room temperature (Hanlon
et al. 2003). Oil red O (0.5% wt/vol stock
solution; Sigma) mixed with water (60:40)
was used to stain cells (3 mL for 30 min).
Dye was extracted from cell culture dishes
with isopropanol (1 mL), and the absorbance
was measured spectrophotometrically at
510 nm (Ramirez-Zacarias et al. 1992).
GPDH activity. Cells were rinsed with
ice-cold PBS, scraped into 0.2 mL extraction
buffer (GPDH assay kit; TAKARA Bio Inc.,
Shiga, Japan), and centrifuged for 10 min at
40°C. GPDH activity was assayed in the
supernatant by monitoring the decrease in
absorbance at 340 nm of NADH in the pres-
ence of dihydroxyacetone phosphate (Wise
and Green 1979).
RNA isolation and gene expression analy-
sis using real-time polymerase chain reaction
(PCR). Total RNA was extracted from tis-
sues or cells using the phenol guanidine-
isothiocyanate method (TRIZOL kit;
Invitrogen) per the manufacturer’s instruc-
tions. Total RNA (0.4 µg) was reverse tran-
scribed for 1 hr at 55°C with the following
components: random decamers, 10× reverse
transcription buffer, deoxynucleotide triphos-
phate mix, ribonuclease inhibitor, and reverse
transcriptase (RETROscript; Ambion,
Austin, TX). The reverse-transcribed cDNA
obtained was then ampliﬁed using an iCycler
(Bio-Rad, Hercules, CA) with the SYBR
Green PCR core reagents kit (Applied
Biosystems, Foster City, CA). The ingredi-
ents used for the PCR in a total reaction
volume of 50 µL included SYBR Green
mix (1×), MgCl2 (3 mM), dNTP mix
(1.25 mM), fluorescein (0.01 µM), primers
(0.5 µM), and Amplitaq gold polymerase
(2.5 units). Relative quantification of gene
expression in the samples was then per-
formed using the standard curve method,
and a ratio to 18s rRNA (reference gene) was
tabulated. The primers (Qiagen, Valencia,
CA) were designed using Primer 3 software
(SourceForge, Mountain View, CA), and the
sequences are shown in Table 1. The PCR
conditions were as follows: 94°C for 5 min,
40 cycles at 94°C for 1 min, 64°C for 1 min,
72°C for 1 min, and a final elongation step
of 72°C for 10 min.
Measurement of PCBs in cells, plasma,
and tissue. For the separation of analytes, we
used a fully automated Dionex ASE 200 sys-
tem (Dionex Corporation, Sunnyvale, CA)
for assisted solvent extraction and gel permea-
tion chromatography/mass spectrometry
(Sipka et al. 2008). This system works by
pumping a solvent (hexane) into the top of an
electrochemical detection cell, which contains
the sample and any in-cell cleanup options.
The cell is brought to elevated pressure and
temperature, then the extract is forced out of
the bottom of the cell and collected in a vial
for additional cleanup if necessary. Detection
was performed with two microelectron cap-
ture detectors; we used Chemstation software
(Agilent, Palo Alto, CA) to run the system
and interpret the chromatograms. An external
standard mixture of PCBs, at known concen-
trations, was used to test for recovery of the
extraction and quantification of PCBs. The
limits of detection for PCBs were 0.1 ng/g of
tissue (or 0.05 ppm), with coefﬁcient of vari-
ability < 3.5% and accuracy (error < 1.5%).
Measurement of adipokines in media from
adipocytes. We measured adipokines in the
media of adipocytes using a Luminex multi-
analyte detection platform (Mouse Adipocyte
Panel; Cayman, Ann Arbor, MI). Values are
picograms per milliliter of cell culture media.
Animal treatments and sample collection.
Male C57BL/6 mice or AhR–/– mice (The
Jackson Laboratory, Bar Harbor, ME) at
3 months of age (n = 10 mice/group) were
housed in a pathogen-free environment. Mice
were given free access to food and water. All
procedures were approved by the Animal
Care and Use Committee at the University of
Kentucky. Mice were administered vehicle
(safﬂower oil, 0.4 mL) or PCB-77 (49 mg/kg,
0.4 mL) by intraperitoneal (ip) injection for a
total of four injections (two in week 1, two in
week 4) during the 6-week study duration.
Body weight was measured weekly. In sepa-
rate studies, 3-month-old male ApoE–/– mice
bred in-house to C57BL/6 mice from stock
originally purchased from The Jackson
Laboratory (n = 10 mice/group) were
administered vehicle (safﬂower oil, 0.4 mL ip)
or PCB-77 (49 mg/kg, 0.4 mL ip) using the
same experimental protocol (a total of four
injections: two in week 1, two in week 4) dur-
ing the 6-week study duration. At the study
end point, mice were anesthetized with keta-
mine/xylazine (100/10 mg/kg ip) for blood
and tissue harvest.
Serum cholesterol measurement. We
determined serum cholesterol concentrations
and lipoprotein cholesterol distributions in
ApoE–/– mice in each treatment group as
described previously (Daugherty et al. 2000;
Manning et al. 2003).
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Table 1. Primer sequences for real-time PCR.
Gene Forward Reverse
18S CTCTGTTCCGCCTAGTCCTG AATGAGCCATTCGCAGTTTC
PPARγ GATGGAAGACCACTCGCATT AACCATTGGGTCAGCTGCTCTTG
aP2 TCACCTGGAAGACAGCTCCT AAGCCCACTCCCACTTCTTT
CD36 AGGTCCTTACACATACAGAGTTCG GGACTTGCATGTAGGAAATGTGGA
Adiponectin GTTGCAAGCTCTCCTGTTCC ATCCAACCTGCACAAGTTCT
Angiotensinogen TCTCTTACCCCTGCCCTCT GAACCTCTCATCGTTCCTTG
Abbreviations: aP2, adipocyte fatty acid–binding protein; PPARγ, peroxisome proliferator–activated receptor γ.Histology. A portion of each tissue
(mesenteric fat, liver) from ApoE–/– mice in
each treatment group was fixed in 4% para-
formaldehyde overnight, embedded in paraf-
ﬁn, and cut in serial sections (5 µm). Sections
were deparaffinized and stained with hema-
toxylin and eosin. Adipocyte area was quanti-
fied in three sections for each mouse (three
fields per section) using an Olympus BX51
microscope and Olympus U-CMAD3 digital
camera (Olympus America, Center Valley,
PA) and Image-Pro Plus 4.5 software (Media
Cybernetics Inc., Bethesda, MD).
Quantification of atherosclerosis. Frozen
aortic root tissues from ApoE–/– mice in each
treatment group were sectioned and discarded
until the aortic sinus was reached. Tissue sam-
ples (10 µM) were subsequently sectioned
and placed on slides (Probe-on Plus; Fisher
Scientiﬁc, Pittsburgh, PA). From the start of
section acquisition at the aortic sinus, each
section was retained and sequentially placed
on 8 slides. A total of 10 slides, each having
approximately nine sections 90 µm apart cov-
ering approximately 720 µm of the root, were
stained for lipid using oil red O. Using a
Digital DXM camera (Nikon Instruments
Inc., Melville, NY) mounted on a microscope,
images (40×) were taken and the area of lesions
quantiﬁed using Image-Pro Software Plus 4.5.
Statistical analysis. Data are expressed as
mean + SE. Data were tested for normality
and equal variance. For in vitro studies com-
paring effects of PCB-77 with PCB-153, data
were analyzed using one-way analysis of vari-
ance (ANOVA) (GraphPad Prism, version 4;
GraphPad Software Inc., San Diego, CA). For
studies examining concentration dependence
of PCB-77 or TCDD, data were analyzed by
two-way ANOVA, with toxic compound and
concentration as between-group factors. For
post hoc analysis, data were analyzed using
Tukey’s test, with signiﬁcance at p < 0.05. For
studies in C57BL/6 and AhR–/– mice, body
weight gain was analyzed by one-way
ANOVA with repeated measures on time. For
studies in ApoE–/– mice, with the exception of
body weight, data were analyzed by Student’s
independent t-test. Signiﬁcance was accepted
at p < 0.05.
Results
PCB-77 promotes 3T3-L1 adipocyte differen-
tiation and the expression of proinﬂammatory
adipokines. We examined the effects of copla-
nar PCB-77 and nonplanar PCB-153 at
equivalent concentrations (3.4 µM) (Hennig
et al. 1999, 2002b) on the differentiation
of 3T3-L1 adipocytes. PCB-77, but not
PCB-153, increased oil red O staining
(Figure 1A). Expression (mRNA) of peroxisome
proliferator–activated receptor γ (PPARγ), a
master regulator of adipocyte differentiation,
and its downstream target, adipocyte fatty
acid–binding protein (aP2), were increased by
PCB-77, but not by PCB-153 (Figure 1C).
PCB-77 resulted in an increase in mRNA
expression of angiotensinogen (Ao), tumor
necrosis factor α (TNF-α), and differentia-
tion-36 (CD36) (Figure 1C). In contrast,
adiponectin mRNA expression and concen-
trations in cell media (Table 2) were
decreased by PCB-77. In addition, PCB-77
increased the concentrations of monocyte
chemoattractant protein-1 (MCP-1) and
keratinocyte chemoattractant-1 (KC-1) in cell
media (Table 2).
The ability of PCB-77 to promote
adipokine expression when incubated with
preadipocytes could result from enhanced
adipocyte differentiation. We therefore exam-
ined the effect of PCB-77 and PCB-153 on
mRNA abundance of adipokines when
incubated with mature differentiated adipo-
cytes (day 8) for 24 or 48 hr. The late-stage
differentiation marker, GPDH activity, was
increased by PCB-77 (Figure 2A; 48-hr incu-
bation). In addition, oil red O staining was
increased by PCB-77 (Figure 2A; 48-hr incu-
bation). After 24 hr incubation, PCB-77
increased the mRNA expression of PPARγ,
Ao, aP2, and CD36 (Figure 2B).
The concentration-dependent effects of
PCB-77 versus TCDD and the role of the
AhR. PCB-77 has afﬁnity for AhRs; TCDD, a
potent AhR ligand, has been shown to inhibit
adipocyte differentiation at concentrations
> 1 nM (Alexander et al. 1998). We therefore
compared the concentration-dependent effects
of PCB-77 (3.4, 34, and 68 µM) with TCDD
(0.1, 1, and 10 nM) on the differentiation of
3T3-L1 adipocytes. We chose PCB-77 con-
centrations based on a toxic equivalency factor
(TEF; compares the relative potency of a com-
pound with TCDD, assigned as 1.0 TEF) of
0.0001 (Van den Berg et al. 2006). Thus, at a
PCB-77 promotes obesity-associated atherosclerosis
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Table 2. Adipokines released from 3T3-L1 adipocytes incubated with vehicle or PCB-77.
MCP-1 (pg/mL) Adiponectin (pg/mL) Leptin (pg/mL) IL-6 (pg/mL) KC-1 (pg/mL)
Vehicle 3,069 ± 297 43,200 ± 1,400 7.78 ± 2.3 5.6 ± 0.1 2,912 ± 321
PCB-77 (3.4 µM) 7,217 ± 1,238* 16,550 ± 250* 4.98 ± 1.7 8.6 ± 2.3 4,820 ± 794*
PCB-77 (68 µM) 1,510 ± 128 129 ± 80* < 3.00 2.8 ± 0.1 < 3.00
TCDD (10 nM) 2,810 ± 430 1,106 ± 325* < 3.00 3.8 ± 0.7 < 3.00
IL-6, interleukin 6. Data are mean ± SE from three per treatment.
*Signiﬁcantly different from vehicle (p < 0.05).
Figure 1. Effect of PCB-77 and PCB-153 on adipocyte differentiation and mRNA expression of proinﬂamma-
tory adipokines. (A) Macroscopic (left) and microscopic (right; 40× magnification) images of oil red
O–stained adipocytes. (B) Quantification of oil red O staining. (C) mRNA expression of PPARγ, aP2, Ao,
TNF-α, CD36, and adiponectin. Data are mean ± SE from ﬁve individual experiments.
*Signiﬁcantly different from vehicle (p < 0.05).
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Bconcentration of 3.4 µM, PCB-77 would be
anticipated to be approximately equipotent
to 0.1 nM TCDD. At low concentrations of
PCB-77 (3.4 µM), oil red O staining
increased (Figure 3). Modest elevations in oil
red O staining with low concentrations of
TCDD (0.1 nM) were not significant com-
pared with vehicle (Figure 3B). Higher con-
centrations of each toxic compound resulted in
a reduction in oil red O staining (Figure 3A).
Because adipocytes were not clearly visible
with high concentrations of TCDD or
PCB-77, we did not quantify oil red O stain-
ing at high concentrations. The AhR antago-
nist α-NF decreased oil red O staining
(Figure 3B). In addition, α-NF decreased
PCB-77 (3.4 µM)-induced elevations in oil
red O staining. In contrast to findings with
lower concentrations of PCB-77 (3.4 µM), a
higher concentration of PCB-77 (68 µM) and
TCDD resulted in a reduction in release of
proinﬂammatory adipokines from adipocytes
when incubated with preadipocytes during
differentiation (Table 2).
In vivo administration of PCB-77
increases body weight gain in C57BL/6, but
not in AhR–/– mice. To determine if the
in vitro effects of PCB-77 occur with in vivo
exposure and whether these effects are AhR-
mediated, we administered PCB-77 to
C57BL/6 wild-type (WT) and AhR–/– mice.
AhR-deficient mice administered vehicle
exhibited lower body weight gain than vehicle-
injected WT controls (Figure 4). In WT mice
administered PCB-77, body weight gain
increased at 1 and 5 weeks compared with
vehicle. In contrast, body weight gain did not
increase in AhR–/– mice administered PCB-77.
In vivo administration of PCB-77 results
in increased body weight and adipose mass,
elevated serum cholesterol concentrations, and
increased atherosclerosis in ApoE–/– mice. To
determine whether elevations in body weight
would promote obesity-associated atheroscle-
rosis, we deﬁned effects of PCB-77 in hyper-
cholesterolemic ApoE–/– mice. Body weight
(28.0 ± 0.70 g for vehicle; 30.4 ± 0.30 g for
PCB-77; p < 0.05; Figure 5A) and weight
gain (1.28 ± 0.4 g for vehicle; 2.62 ± 0.30 g
for PCB-77; p < 0.05) were higher in
PCB-77–treated mice compared with vehicle-
treated mice. Increases in body weight were
Arsenescu et al.
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Figure 2. Effect of PCB-77 and PCB-153 on mRNA expression of proinflammatory adipokines in mature
3T3-L1 adipocytes. (A) GPDH activity (left) or oil red O staining (right). (B) mRNA expression of PPARγ, aP2,
Ao, or CD36. Data are mean ± SE from ﬁve individual experiments. 
*Signiﬁcantly different from vehicle (p < 0.05).
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Figure 3. Effects of low and high concentrations of PCB-77 and TCDD on adipocyte differentiation (effects of PCB-77 are AhR mediated). (A) Oil red O staining (represen-
tative images from three individual experiments; 20×magniﬁcation). (B) Quantiﬁcation of oil red O staining. Data are mean ± SE from three experiments.
*Signiﬁcantly different from vehicle (p < 0.05). **Signiﬁcantly different from PCB-77/α-NF (p < 0.05).
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Bassociated with increases in the mass of
gonadal [epididymal fat (EF)] and visceral
[retroperitoneal fat (RPF)] adipose tissue as
well as the liver (Figure 5B). In tissue sections
from mesenteric white adipose tissue,
adipocytes from mice injected with PCB-77
were hypertrophied compared with those
from vehicle-treated mice (Figure 5C,D). The
concentration of PCB-77 in EF was higher in
mice administered PCB-77 (55±8µ g/g)
than in vehicle-treated animals (< 0.6 µg/g).
Moreover, PCB-77 was not detected in the
plasma of vehicle-injected mice, but it was
within detectable concentrations in mice
administered PCB-77 (0.365 µg/g).
Total serum cholesterol concentrations
were markedly increased in ApoE–/– mice
injected with PCB-77 compared with vehicle
(Figure 6A). Elevations in serum cholesterol
concentrations in PCB-77–treated mice were
predominantly in very low-density lipoprotein
(VLDL) cholesterol (Figure 6B). Moreover,
compared with vehicle-treated mice, tissue sec-
tions of liver from mice administered PCB-77
exhibited lipid-laden vacuoles (Figure 6C).
Unexpectedly, administration of PCB-77
resulted in marked deposition of lipid within
the abdominal cavity (Figure 6D). The extent
of atherosclerosis was low in aortic root sec-
tions of ApoE–/– mice administered vehicle
(Figure 6E). Administration of PCB-77 to
ApoE–/– mice increased atherosclerosis in aortic
root sections (0.002 µm2 mean lesion area in
PCB-77–injected mice; nondetectable in vehi-
cle controls; p = 0.032; Figure 6E).
Discussion
It has long been recognized that the high
lipophilicity of PCBs and related toxic com-
pounds favors their localization to adipose tis-
sue. However, their effects on adipocyte
function have not been established. Our results
suggest that lower concentrations of coplanar
PCBs, acting as ligands of the AhR, promote
adipocyte differentiation and increase the
expression of proinﬂammatory adipokines. In
contrast, higher concentrations, similar to
TCDD, inhibit adipocyte differentiation.
Importantly, when administered to WT, but
not AhR-deficient mice, PCB-77 caused an
increase in body weight gain. These results con-
ﬁrm in vitro ﬁndings and suggest that effects
of PCB-77 are AhR mediated. In hypercholes-
terolemic ApoE–/– mice, PCB-77 increased
body weight associated with adipocyte hyper-
trophy, expanded adipose mass, and increased
serum cholesterol concentrations and ectopic
lipid deposition. These effects of PCB-77 were
associated with increased atherosclerosis.
These results suggest that exposure to
PCB-77, a dioxin-like PCB, at relatively low
levels may promote the development of obe-
sity and obesity-associated atherosclerosis.
PCBs are highly lipophilic, with
octanol:water partition coefficients of ≥ 104,
making their accumulation in nonlipid mate-
rial negligible. In studies aimed at determining
the congener-specific distribution of PCBs
with chronic exposure, adult rats were treated
ﬁve times per week for 4 weeks by gavage with
Aroclor 1254 in corn oil (Kodavanti et al.
1998). Total PCB (parts per milllion) accumu-
lation in fat was 551 µg/g; the second-highest
tissue accumulation of PCBs was in liver
(38 µg/g). The mean blood:liver:fat tissue
ratios were 1:22:359, similar to previously
observed results for PCB-153 (Wyss et al.
1986) or 2,2´3´,4,4´,5,5´-heptachlorobiphenyl
(PCB-180) (Koss et al. 1993). In the present
study, adipocyte differentiation and proinﬂam-
matory adipokine expression were induced in
3T3-L1 adipocytes by PCB-77 but not by
PCB-153. These PCB congeners differ slightly
in their oil:water partition coefﬁcients, favoring
greater lipophilicity of PCB-153; however,
both PCBs would be anticipated to accumulate
in adipose tissue. A lack of effect of PCB-153
may have resulted from greater sequestration of
this more-lipophilic PCB in the triacylglycerol
droplet of the adipocyte, leaving less PCB-153
available to act at adipocyte target proteins.
However, given that PCB-77 and TCDD
PCB-77 promotes obesity-associated atherosclerosis
Environmental Health Perspectives • VOLUME 116 | NUMBER 6 | June 2008 765
Figure 4. Effect of PCB-77 on body weight gain in WT
C57BL/6 and AhR–/– mice. Arrows indicate times of
vehicle or PCB-77 injections. Data are mean ± SE
from 10 mice per group.
*Signiﬁcantly different from vehicle, within genotype.
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Figure 5. Effect of PCB-77 on body weight, adipose mass, and liver weight in ApoE–/– mice. (A) Body weight
(arrows indicate times of vehicle or PCB-77 injections). (B) Weights of EF, RPF, and liver (percentage of
body weight). (C) Tissue sections from mesenteric adipose tissue. (D) Quantiﬁcation of adipocyte surface
area (percentage of total section surface area; right) in representative tissue sections of mesenteric (Mes)
adipose tissue. Data are mean ± SE from 10 mice per group.
*Signiﬁcantly different from vehicle (p < 0.05).
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C Dexhibited similar effects and that TCDD has a
high octanol:water partition coefﬁcient compa-
rable to PCB-153 (6.7 vs. 6.8, respectively),
other mechanisms most likely mediated differ-
ences in effects of PCB-77 and PCB-153.
Specifically, results from this study demon-
strate that interactions with the AhR, for which
both PCB-77 and TCDD possess afﬁnity (but
PCB-153 has low afﬁnity), contributed to dif-
ferences in the effects of these PCBs.
Phillips et al. (1995) demonstrated that
treatment of 3T3-L1 preadipocytes with
10 nM TCDD during the first 2 days of
induction of differentiation resulted in a reduc-
tion in the number of fat cell colonies. The
effect of TCDD to inhibit adipocyte differenti-
ation was blocked by treatment with an AhR
antagonist. To extend these findings to the
in vivo situation, Brodie et al. (1996) demon-
strated that a single high dose (175 µg/kg) of
TCDD administered to rats resulted in inhibi-
tion of adipocyte differentiation. Additional
studies by this group demonstrated that high-
dose TCDD treatment in rats resulted in a
reduction in preadipocyte differentiation to
mature adipocytes, which was associated with
decreases in transcription factor mRNAs
(PPARγ, aP2, C/EBPβ) normally elevated dur-
ing adipocyte differentiation (Brodie et al.
1997). Using the 3T3-L1 adipocyte differentia-
tion system, Shimba et al. (1998) demonstrated
that the level of AhR protein decreased with
ongoing adipocyte differentiation. Using
mouse embryo fibroblasts, Alexander et al.
(1998) demonstrated that treatment with
10 nM TCDD inhibited differentiation in
cells from WT but not AhR–/– mice. At high
concentrations (approximately 10-fold greater
than the dissociation constant), the literature
and data from this study demonstrate that
TCDD decreases adipocyte differentiation,
commensurate with the wasting syndrome
demonstrated from high-dose toxicity.
Several epidemiologic studies have sug-
gested a link between exposure to dioxin, or
PCBs, and diabetes (Bertazzi et al. 1997;
Calvert et al. 1999; Codru et al. 2007;
Cranmer et al. 2000; Lee et al. 2006, 2007a;
Vasiliu et al. 2006). Most of these studies rep-
resent findings from type 2 diabetics with
obesity; however, increased relative risk for
exposure to toxic compounds and the devel-
opment of diabetes remains when data were
adjusted for differences in body mass index
across study populations. Interestingly, the
association between persistent organic pollu-
tants and diabetes was much stronger in obese
subjects compared with lean subjects (Lee
et al. 2006). Moreover, in nondiabetic adults,
results from the National Health and
Nutrition Examination Survey (1999–2002)
(Lee et al. 2007b) demonstrated a linear posi-
tive relationship between serum concentra-
tions of PCBs, including dioxin-like PCBs,
and waist circumference. Unfortunately, simi-
lar epidemiologic studies have not been per-
formed to define whether exposure to PCBs
increases the risk for development of obesity
or obesity-associated cardiovascular disease,
including atherosclerosis.
Obesity, a condition that would pre-
dictably increase the body burden of lipophilic
PCBs, is associated with an elevation in the sys-
temic concentrations of a variety of factors that
are produced and released from adipocytes
(Lago et al. 2007; Lau et al. 2005). Many of
these factors have been linked to diseases
clustering around an obesity phenotype,
including coronary artery disease, the primary
cause of death in the obese population. Thus,
factors that regulate adipokine secretion from
adipocytes may inﬂuence not only obesity but
also obesity-associated atherosclerosis. The pre-
sent results demonstrate that PCB-77 pro-
motes the expression and secretion of a variety
of proinﬂammatory adipokines from 3T3-L1
adipocytes and decreases the expression of
adiponectin, an anti-inﬂammatory adipokine.
Although previous studies have demonstrated
proinﬂammatory effects of PCBs in various cell
types (Choi et al. 2003; Eum et al. 2006;
Hennig et al. 1999, 2002b; Ramadass et al.
2003), to our knowledge, this is the ﬁrst report
demonstrating that PCBs can promote the
production and elaboration of these factors
from adipocytes. Interestingly, Vogel et al.
(2007) recently reported that a single injec-
tion of TCDD to C57BL/6 mice resulted in
an increase in MCP-1 and KC-1 in liver and
adipose tissue. However, enhanced expression
of these adipokines in adipose tissue was asso-
ciated with increased expression of the
macrophage marker F4/80, suggesting that
this effect may have resulted from enhanced
macrophage infiltration into adipose tissue.
Our results extend these ﬁndings by demon-
strating that PCB-77 can act directly on
3T3-L1 adipocytes to promote the mRNA
abundance and secretion of several pro-
inﬂammatory adipokines.
To extend results from in vitro experiments
to an in vivo model, we administered PCB-77
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Figure 6. Effects of PCB-77 on total serum cholesterol and VLDL cholesterol concentrations, lipid deposi-
tion within the liver and abdominal cavity, and atherosclerosis in ApoE–/– mice. (A) Total serum cholesterol
concentrations (n = 10 mice per group). (B) Lipoprotein cholesterol distributions (n = 4 mice per group).
(C) Representative tissue sections from livers of mice injected with vehicle or PCB-77. (D) Abdominal cav-
ity from mice administered vehicle or PCB-77. (E) Aortic root sections stained with oil red O from vehicle or
PCB-77–injected mice.
*Signiﬁcantly different from vehicle (p < 0.05).
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Vehicle PCB-77to WT or AhR-deficient mice or to hyper-
cholesterolemic ApoE–/– mice. In previous stud-
ies, C57BL/6 mice that received 30 mg/kg/day
of PCB-77 consumed in food for a total of
16 weeks exhibited a reduction in body weight
(Goodwill et al. 2007). Thus, chronic dosing
with high doses of PCB-77 appears to mimic
the wasting syndrome that results from toxic
TCDD exposure. In the present study, we
injected mice four times (49 mg/kg per dose)
with PCB-77 over a 6-week period; although
this was a higher daily dose than used by
Goodwill et al. (2007), it was far less cumula-
tive. Our choice of PCB-77 dose was based on
previous studies demonstrating that this dose
exhibits proinﬂammatory effects on endothelial
cells when injected into mice (Hennig et al.
2002b) and is classiﬁed as a moderate exposure
dose in experimental animals (Brouwer et al.
1999; Jensen et al. 2001; Wassermann and
Wassermann 1979). In agreement, PCB-77
levels in adipose tissue of mice from this study
were far lower than those reported in adipose
tissue from rats administered Arochlor [55 vs.
551 µg/g; (Kodavanti et al. 1998)]. Our results
demonstrate that in contrast to high-dose
PCB-77 dosing in vivo, lower doses exhibit
an opposite effect to increase body weight.
Moreover, these effects were AhR mediated.
The ability of PCB-77 to increase adipose mass
with associated adipocyte hypertrophy may
relate to the in vitro effects of PCB-77 to pro-
mote adipocyte differentiation. Alternatively,
the ability of PCB-77 to increase CD36
mRNA abundance in adipocytes may have
promoted lipid uptake and contributed to
adipocyte hypertrophy.
Previous investigators demonstrated that
dietary exposure to PCBs results in fatty liver
and hypercholesterolemia in rats (Kato et al.
1980; Nagaoka et al. 1990; Quazi et al. 1983).
These effects were primarily attributed to an
increase in hepatic cholesterol synthesis. In the
present study, a low dose of PCB-77 resulted
in a marked increase in serum cholesterol con-
centrations in ApoE–/– mice, with predomi-
nant increases in VLDL cholesterol. These
results extend previous ﬁndings by demonstrat-
ing that in a mouse model exhibiting hyper-
cholesterolemia and atherosclerosis, marked
elevations in serum cholesterol concentrations
are induced by PCB-77. Moreover, elevations
in VLDL cholesterol by PCB-77 in this study
were associated with increased atherosclerosis.
To our knowledge, this is the ﬁrst study that
has directly examined the effects of PCB expo-
sure on experimental atherosclerosis.
In conclusion, at low exposure levels,
coplanar PCB-77 promoted adipocyte differ-
entiation and proinflammatory adipokine
expression. In contrast, both PCB-77 and
TCDD inhibited adipocyte differentiation at
higher concentrations. Effects of PCB-77 to
promote adipocyte differentiation and regulate
body weight were AhR mediated. Importantly,
when administered in vivo to ApoE–/– mice at
a moderate dose, PCB-77 resulted in an
increase in body weight, adipose mass and
adipocyte area, serum cholesterol concentra-
tions, and atherosclerosis. These results suggest
that low-level exposure to coplanar PCBs may
contribute to the development of obesity and
to obesity-associated atherosclerosis.
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